Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants

▤ Summary

Structure Therapeutics announced the pricing of an upsized public offering that is expected to raise about $650 million before expenses. The company is selling ADSs and pre-funded warrants, and it also gave underwriters a 30-day option to buy more ADSs. The deal is scheduled to close on December 11, 2025, subject to normal closing conditions. This matters for investors because it signals access to significant capital for a clinical-stage biopharmaceutical company focused on metabolic disease treatments.

$ Funding

▦ Linked Companies